The relationship between cellular calcium (Ca) metabolism and systemic or skeletal homeostasis are poorly understood. We believe that the increasingly common, distinctive syndrome of familial benigh hypercalcemia (FBH, or hypocalciuric hypercalcemia) provides a unique opportunity for probing the mechanisms of Ca homeostasis. The FBH syndrome includes lifelong, dominantly-inherited hypercalcemia, enhanced renal tublar reabsorption of Ca, nonsuppressed but not elevated parathyroid hormone (PTH) secretion, generally normal parathyroid histology, and failure of subtotal parathyroidectomy to normalize serum Ca. Affected persons are frequently misdiagnosed as having primary hyperparathyroidism (1oHPT) and given inappropriate treatment. The central hypothesis of the proposed research is that FBH results from a pervasive, congenital alteration of cellular Ca metabolism, and thus differs fundamentally from 1oHPT in not having isolated hyperfunction of the parathyroids. The defect may be increased membrane Ca-Mg ATPase (Ca pump). More than 125 Mayo patients with FBH are available for study. We intend to determine 1) if there are characteristic abnormalities of cytosolic Ca ion levels or regulation, abnormal membrane CA pumping, or abnormal cytosolic Ca-binding proteins in FBH; 2) if intestinal absorption of Ca is enhanced as is renal tubular reabsorption of Ca; 3) whether renal responses to water deprivation and vasopressin administration are similarly altered in FBH and 1oHPT; 4) if FBH patients are hypersensitive to the effects of PTH; 5) if renal phosphorus handling, vitamin D activation, and plasma Ca are affected normally by phosphorus depletion and repletion; and 6) whether bone turnover is increased in FBH. Techniques to be used include in vitro assays of erythrocyte membrane Ca-Mg ATPase and 45Ca flux, measurement of cytosolic Ca ion levels and cytosolic Ca-binding proteins in cultured dermal fibroblasts, infusions of PTH or vasopressin, double isotope Ca absorption, PTH bioassay, assay of bone turnover markers, and bone histomorphometry. Expertise in all areas has been assured through appropriate coinvestigators and consultants. These comprehensive studies should improve knowledge of Ca homeostasis in general, help us to understand the pathogenesis of FBH, and could help in development of specific diagnostic tests for hypercalcemic patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038855-02
Application #
3238413
Study Section
General Medicine B Study Section (GMB)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Nesbit, M Andrew; Hannan, Fadil M; Howles, Sarah A et al. (2013) Mutations affecting G-protein subunit ?11 in hypercalcemia and hypocalcemia. N Engl J Med 368:2476-2486
Hobbs, Maurine R; Rosen, Irving B; Jackson, Charles E (2002) Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2. Am J Hum Genet 70:1376-7
Hobbs, M R; Pole, A R; Pidwirny, G N et al. (1999) Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. Am J Hum Genet 64:518-25
Health 3rd, H; Odelberg, S; Jackson, C E et al. (1996) Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81:1312-7
Szabo, J; Heath, B; Hill, V M et al. (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-50
Thompson, D B; Samowitz, W S; Odelberg, S et al. (1995) Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 80:3377-80
Heath 3rd, H (1994) Familial benign hypercalcemia--from clinical description to molecular genetics. West J Med 160:554-61
Khosla, S; Ebeling, P R; Firek, A F et al. (1993) Calcium infusion suggests a ""set-point"" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76:715-20
Heath 3rd, H; Jackson, C E; Otterud, B et al. (1993) Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53:193-200
Heath 3rd, H; Leppert, M F; Lifton, R P et al. (1992) Genetic linkage analysis in familial benign hypercalcemia using a candidate gene strategy. I. Studies in four families. J Clin Endocrinol Metab 75:846-51

Showing the most recent 10 out of 23 publications